Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002687940 | SCV003555122 | uncertain significance | Inborn genetic diseases | 2021-10-14 | criteria provided, single submitter | clinical testing | The c.884G>A (p.R295Q) alteration is located in exon 9 (coding exon 9) of the NPRL2 gene. This alteration results from a G to A substitution at nucleotide position 884, causing the arginine (R) at amino acid position 295 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Institute of Human Genetics, |
RCV004783030 | SCV005395884 | uncertain significance | Epilepsy, familial focal, with variable foci 2 | 2023-09-08 | criteria provided, single submitter | clinical testing |